tradingkey.logo
tradingkey.logo
Buscar

Inotiv Inc

NOTV
Añadir a la lista de seguimiento
0.080USD
0.0000.00%
Cierre 06/30, 16:00ETCotizaciones retrasadas 15 min
2.79MCap. mercado
PérdidaP/E TTM

Más Datos de Inotiv Inc Compañía

Inotiv, Inc. is a contract research company engaged in providing nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries and selling a range of research-quality animals and diets to the same industries, as well as academia and government clients. Its products and services focus on bringing new drugs and medical devices through the discovery and preclinical phases of development. It operates through two segments: Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through DSA segment, it supports the discovery, nonclinical development and clinical development needs of researchers and clinicians for primarily small molecule drug candidates, as well as biotherapeutics and biomedical devices. Through RMS segment, it offers access to a range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas.

Información de Inotiv Inc

Símbolo de cotizaciónNOTV
Nombre de la empresaInotiv Inc
Fecha de salida a bolsaNov 25, 1997
Director ejecutivoLeasure (Robert W)
Número de empleados- -
Tipo de seguridadOrdinary Share
Fin del año fiscalNov 25
Dirección2701 Kent Ave
CiudadWEST LAFAYETTE
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal47906-1382
Teléfono13174634527
Sitio Webhttps://www.inotiv.com/
Símbolo de cotizaciónNOTV
Fecha de salida a bolsaNov 25, 1997
Director ejecutivoLeasure (Robert W)

Ejecutivos de Inotiv Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. John E. Sagartz, Ph.D.
Dr. John E. Sagartz, Ph.D.
Chief Strategy Officer, Director
Chief Strategy Officer, Director
686.00K
-0.88%
Dr. Adrian Hardy, Ph.D.
Dr. Adrian Hardy, Ph.D.
Chief Commercial Officer
Chief Commercial Officer
373.36K
-1.44%
Mr. John Gregory (Greg) Beattie
Mr. John Gregory (Greg) Beattie
Chief Operating Officer
Chief Operating Officer
180.99K
-3.19%
Dr. Nigel Brown, Ph.D.
Dr. Nigel Brown, Ph.D.
Independent Director
Independent Director
104.93K
+26.21%
Mr. Michael J. Harrington
Mr. Michael J. Harrington
Independent Director
Independent Director
76.89K
+35.76%
Ms. Andrea Castetter
Ms. Andrea Castetter
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
13.20K
-43.94%
Mr. R. Matthew Neff
Mr. R. Matthew Neff
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Robert W. Leasure, Jr.
Mr. Robert W. Leasure, Jr.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Beth A. Taylor
Ms. Beth A. Taylor
Chief Financial Officer, Senior Vice President - Finance
Chief Financial Officer, Senior Vice President - Finance
--
--
Mr. David Landman
Mr. David Landman
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. John E. Sagartz, Ph.D.
Dr. John E. Sagartz, Ph.D.
Chief Strategy Officer, Director
Chief Strategy Officer, Director
686.00K
-0.88%
Dr. Adrian Hardy, Ph.D.
Dr. Adrian Hardy, Ph.D.
Chief Commercial Officer
Chief Commercial Officer
373.36K
-1.44%
Mr. John Gregory (Greg) Beattie
Mr. John Gregory (Greg) Beattie
Chief Operating Officer
Chief Operating Officer
180.99K
-3.19%
Dr. Nigel Brown, Ph.D.
Dr. Nigel Brown, Ph.D.
Independent Director
Independent Director
104.93K
+26.21%
Mr. Michael J. Harrington
Mr. Michael J. Harrington
Independent Director
Independent Director
76.89K
+35.76%
Ms. Andrea Castetter
Ms. Andrea Castetter
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
13.20K
-43.94%

Preguntas frecuentes

¿Quiénes son los cinco principales accionistas de Inotiv Inc?

Los cinco principales accionistas de Inotiv Inc son: Dr. John E. Sagartz, Ph.D.

¿Cuántas instituciones poseen acciones de Inotiv Inc (NOTV)?

A fecha de 2026Q1, 168 instituciones poseen acciones de Inotiv Inc, con un valor de mercado combinado de aproximadamente 8.11M, lo que representa el 23.58% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -4802422.00.
KeyAI